Paclitaxel Teva

Paclitaxel, the active ingredient in Paclitaxel Teva, is a taxane presented as a strength/form for epidural use. It treats various cancers and is administered by healthcare professionals in oncology settings.

GNH USA supplies Paclitaxel Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Paclitaxel is used in several oncologic pathways to inhibit tumor growth: - Breast cancer: Improves the overall response rate when combined with anthracycline‑based regimens. - Ovarian cancer: Enhances the efficacy of platinum based ‑ c‑ ​      t . - Non‑small‑cell NSCLC : Provides a survival benefit in combination with carb . -  t  ",

"mechanism": "[...]",\n "effects": "", "precautions": "", "interactions": "", "metatitle": "", "metadesc": "", "keywords": "", "faqs": [], "schema_jsonld": {} }